WHO Emergency May Compel Big Pharma To Declare State Deals
Under new regulations that would oversee a pandemic agreement approved by the World Health Organization, which Reuters has reviewed, pharmaceutical companies might be required...
IGBA Claims That 2022 WHO Biosimilar Guideline Boosts Access
According to the new whitepaper Embracing Science with Confidence: Adopting the Revised 2022 WHO Biosimilars Guideline from the International Generic and Biosimilar Medicines Association...
Australia Approves Faecal Transplants For Intestinal Health
Australia is the first country in the world to have awarded regulatory approval for faeces transplants.
The healthy genetic material for this donation comes from...
NHS Acquires Potentially Lifesaving Breast Cancer Medication
The confidential agreement reached by the NHS and the manufacturer is expected to assist up to 1,600 women annually who have high-risk, triple-negative breast...
Food And Drug Administration User Fee Has Been Reauthorized
As anticipated, Congress swiftly reauthorized four important user fee programmes as part of a bill that was essential to passing in order to continue...
EMA Wants To Limit Immune-Regulating Medications Like FDA
On October 28th, an advisory board to the European Medicines Agency advised restricting the use of a class of medications for inflammatory diseases due...
FDA Under Strain To Amend The Accelerated Approval Program
The necessity to update and alter the FDA's now-contentious rapid approval strategy is highlighted by the protracted, complicated FDA process to discontinue commercialization of...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...